Jeffrey Langsam Oncology Institute, Inc. (TOI) insider trading activity
Jeffrey Langsam is Chief Clinical Officer of Oncology Institute, Inc.. Currently has a direct ownership of 57,380 shares of TOI, which is worth approximately $146,892. The most recent transaction as insider was on May 21, 2025, when has been sold 57,380 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
57.4K
n/a
3M change
n/a
12M change
Total Value Held
$146,892
JL
Jeffrey Langsam
Chief Clinical Officer
Cerritos, CA